One Medical Passport Receives $4M Series A Investment by FCA Venture Partners to Accelerate Growth

One Medical Passport, Inc., a leading provider of cloud-based peri-operative medical software, announced today that it has closed a $4 million Series A investment from FCA Venture Partners, a Nashville-based venture capital firm focused on healthcare IT. One Medical Passport’s online software is used by over two million patients and 700 medical facilities annually throughout the U.S., and its customers include many of the top healthcare management companies.

Read More
FCA V Company, ChartWise Medical Solutions, Honored as a Red Herring Top 100 North America Winner

FCA V Portfolio Company, ChartWise Medical Systems, Inc., was selected a Red Herring Top 100 North America Winner.  This award recognizes ChartWise as one of the technology industry’s top private companies.

The Red Herring Top 100 North America winners represent outstanding entrepreneurs and promising companies. Award winners are chosen from approximately 1,200 privately financed companies each year in the US and Canada. A review of the track record and standing of startups relative to their sector peers, allowed Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in North America, complement this assessment of potential.

Read More
Clayton Associates Names Kloess Chairman

Clayton Associates announced that Larry Kloess has been named Chairman of the firm. This follows the recent announcement that the firm’s co-founder, Stuart McWhorter, will leave his day-to-day role as president and chairman of Clayton Associates to become CEO of the Nashville Entrepreneur Center.

Read More
Andrew Bouldin
Ardent Health Services to be Acquired by Ventas for $1.75 Billion

Ventas announced today that it has signed a definitive agreement to acquire privately-owned Ardent Medical Services, Inc. (with its affiliates “Ardent Health Services”), a premier provider of health care services and one of the ten largest for-profit hospital companies in the U.S., for $1.75 billion in cash. The transaction is expected to be immediately accretive to Ventas’s normalized funds from operations (“FFO”) per share by $0.08 to $0.10 in the first full year after close.

Read More
Andrew Bouldin